Pay for your much needed therapy this week with your profits from a continuation on a SGMOtheraputics breakout. If you missed area of value as outlined by my post last friday we could still be in a good buy position for continuation of this breakout. Safe trading!
SGMO is in the gene editing space. Nice setup as it successfully tested the breakout spot and found support. Now launching higher today off key moving averages. CRSP reports earnings this week so we could see a positive catalyst. I took some May $15 calls today.
This is a GREAT stock that has an extremely clear bottom and only $7 which means options and just buy and selling is easy. Right now it is extremely obvious.
Buy in around $4 to $4.75 UNLESS it breaks this upper resistance, but even if it does there are some resistance levels $9-$11 range. So I would be careful if you are bullish where it is at now.
Recent data release may have changed SGMO's future outlook. Sangamo's long-term chart suggests a potential pullback to $4 is a possibility, but that was before a recent data release by the company for updated Phase 1/2 Results for SB-525 . This is an investigational Hemophilia-A gene therapy that showed sustained increased Factor VIII Levels with no reported...
If this supply zone can be taken out by bulls, buyers will be starting to take control as supply zones are starting to get destroyed and demand zones are being created.
If the trend does change, can start looking for long orders.
Sangamo Therapeutics, Inc. is a company that develops genomic therapies, using genome editing, gene therapy, gene regulation, and cell therapy. It's an interesting addition to your swing trading portfolio, specially now that it is ready to start trending up after being accumulated after enduring an extensive correction, now trading at a 40% discount from recent...